Delivery Order SPE2DR25D1106-SPE2DR26FJF2M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 14, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-count packages) with a contract ceiling value of $3,013.92. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded procurement. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December...
- The Defense Logistics Agency awarded a $4,622.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray on November 28, 2025, with an ultimate completion date of December 1, 2025. This award is a non-set-aside contract and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Naloxone HCL 4 mg nasal spray with a firm fixed price ceiling value of $2,998.20 and an ultimate completion date of November 10, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naloxone 4mg nasal spray (2-count units) under a firm fixed-price contract with a ceiling value of $1,206.15. The award, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This order...
- The Defense Logistics Agency awarded a delivery order valued at $2,503.20 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,519.77 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-count units) on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. Performance will be executed from the company's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a $3,834.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-dose units) on December 10, 2025, with an ultimate completion date of December 11, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,255.47 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on November 7, 2025, with completion targeted for November 10, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $10,635.64. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 6, 2025. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $1,100.49. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made on...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJF2MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 27, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-count units) with a ceiling value of $3,708.70. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the open market. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 29, 2025. As a child contract, this delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Department of Defense healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a broad range of pharmaceutical products and medical commodities, including specialty medications, vaccines, and medical devices, supporting military healthcare programs worldwide. This naloxone delivery order reflects the company's ongoing role in supplying essential medical products to support Defense Health Agency operations and other federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 12/26/25 |